Key Drivers
- Strong Liquidity
- Heavy Cash Burn
- Worsening Profitability
AIAI Summary
PSNL is now primarily a stock-funded Tempus merger-arbitrage investment, with limited upside above the $16.25 consideration and meaningful downside if Tempus shares weaken, closing is delayed, or the deal fails—so investors should prioritize transaction terms and completion probability over Personalis' standalone growth story.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Heavy Cash Burn
- •Worsening Profitability
PSNL's strong liquidity and low leverage provide a near-term cushion, but severe losses, accelerating cash burn, margin pressure, dilution, and elevated valuation make the shares high risk.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support defense
- •Weak momentum
PSNL remains cautiously bearish last month, with support at $16.10–$16.20; a move above $16.60 would improve momentum, while a break below $16.10 risks further downside.
Rebounded from $16.10 to $16.40 after recent selling
Sentiment & News
Key News Insights:
- •Bank buying surge
- •Split analyst ratings
- •Investor investigation
Personalis saw strong institutional buying but mixed analyst views and shareholder scrutiny, warranting cautious monitoring.
The mixed signals and legal scrutiny could increase near-term PSNL volatility despite institutional support
Similar Companies in Healthcare
Other companies in the same sector with AI ratings